Search Results

Tim De Groof! It’s not often when you get the best of both worlds - nano-bodies and #GPCRs.

April 2022 Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal (Strasbourg, France; CEO: Pascal Neuville; “Domain”) and Université de Montréal (Québec, Canada; “UdM

the Department of Biochemistry and Molecular Medicine of the Faculty of Medicine of the Université de

Timo De Groof About Dr. Timo De Groof Dr. Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in During his last year of studies, Timo performed research in the biopharmaceutical company Argen X and During his Ph.D., Timo, together with Dr. Timo De Groof on the web LinkedIn Researchgate Twitter Medical Imaging Group Google Scholar Dr.

Workshop 2024 , hosted in the vibrant heart of Mexico City at the prestigious venue, CINVESTAV - Centro de Investigación y de Estudios Avanzados del IPN (in English: Center for Research and Advanced Studies About the venue Cinvestav: Centro de investigación y de Estudios Avanzados del IPN Av. Preliminary Program Layout Date Time Title October 23, 2024 October 24, 2024 October 25, 2024 *Flash

The conversation covers the de-orphanization of GPR139 and GPR55, the unresolved promise of biased agonism His group contributed to the de-orphanization of GPR139 and GPR55, including the identification of sub-nanomolar GPCRDB as community infrastructure for integrating and accelerating GPCR research The interdisciplinary de-orphanization De-Orphanization Is a Full-Discipline Effort The process of characterizing an orphan receptor from protein sequence data 11:55 Orphan GPCRs - years spent chasing receptors with no known function or ligand 13:31 De-orphanizing